CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 44 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,855,274 | -31.0% | 2,132,744 | -11.1% | 0.03% | -26.1% |
Q2 2023 | $2,688,385 | +7.7% | 2,400,344 | 0.0% | 0.05% | +9.5% |
Q1 2023 | $2,496,358 | -7.1% | 2,400,344 | 0.0% | 0.04% | -14.3% |
Q4 2022 | $2,688,385 | -0.9% | 2,400,344 | 0.0% | 0.05% | -15.5% |
Q3 2022 | $2,712,000 | -22.8% | 2,400,344 | +0.4% | 0.06% | -21.6% |
Q2 2022 | $3,514,000 | -38.3% | 2,390,344 | -3.8% | 0.07% | -19.6% |
Q1 2022 | $5,692,000 | -33.5% | 2,485,652 | -20.2% | 0.09% | -23.3% |
Q4 2021 | $8,565,000 | -43.5% | 3,114,252 | +23.3% | 0.12% | -36.5% |
Q3 2021 | $15,156,000 | -9.0% | 2,525,952 | -26.1% | 0.19% | -2.1% |
Q2 2021 | $16,655,000 | +90.4% | 3,419,877 | -3.4% | 0.19% | +93.0% |
Q1 2021 | $8,746,000 | -9.9% | 3,540,961 | 0.0% | 0.10% | -1.0% |
Q4 2020 | $9,702,000 | +158.1% | 3,540,961 | +45.1% | 0.10% | +129.5% |
Q3 2020 | $3,759,000 | +3.2% | 2,440,961 | +26.0% | 0.04% | -12.0% |
Q2 2020 | $3,643,000 | +8.2% | 1,937,608 | -2.2% | 0.05% | -12.3% |
Q1 2020 | $3,367,000 | – | 1,980,508 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 2,462,500 | $11,993,000 | 6.16% |
ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $6,410,000 | 2.56% |
AJU IB Investment Co., Ltd. | 293,555 | $1,430,000 | 0.82% |
RTW INVESTMENTS, LP | 4,206,765 | $20,487,000 | 0.31% |
Carmignac Gestion | 3,419,877 | $16,655,000 | 0.19% |
EAM Investors, LLC | 247,561 | $1,206,000 | 0.19% |
Curi Wealth Management, LLC | 25,000 | $121,000 | 0.06% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,542,000 | 0.03% |
TWO SIGMA ADVISERS, LP | 990,000 | $4,821,000 | 0.01% |
CAXTON ASSOCIATES LP | 24,677 | $120,000 | 0.01% |